Aurora Cannabis (ACB) Shares Outstanding (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Shares Outstanding (Entity) of $413.6 million for Q1 2026, up 8.22% year-on-year from $382.1 million in Q1 2025, and up 1.71% on a QoQ basis from $406.6 million in Q4 2025.
Aurora Cannabis (ACB) Shares Outstanding (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Shares Outstanding (Entity) for 10 consecutive years, with $413.6 million the latest figure, recorded in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 8.22% year-over-year to $413.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $413.6 million (up 8.22% YoY) and the FY2026 annual result came in at $410.4 million, up 4.04% from the prior year.
- Shares Outstanding (Entity) rose to $413.6 million in Q1 2026 per ACB's latest filing, from $406.6 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for ACB reached as high as $413.6 million in Q1 2026 and fell as low as $16.9 million in Q2 2022.
- A 5-year average of $218.0 million and a median of $320.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) jumped 1336.73% — and 2025, when it advanced 2.34%.
- Year by year, Shares Outstanding (Entity) stood at $24.0 million in 2022, then surged by 44.84% to $34.8 million in 2023, then jumped by 1027.76% to $392.8 million in 2024, then increased by 3.5% to $406.6 million in 2025, then advanced by 1.71% to $413.6 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $413.6 million, $406.6 million, and $410.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 56.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.71 Mn |
| Dec 31, 2025 | 56.70 Mn |
| Sep 30, 2025 | 56.46 Mn |
| Jun 30, 2025 | 56.24 Mn |
| Mar 31, 2025 | 54.83 Mn |
| Dec 31, 2024 | 54.88 Mn |
| Sep 30, 2024 | 54.68 Mn |
| Jun 30, 2024 | 51.72 Mn |
| Mar 31, 2024 | 43.22 Mn |
| Dec 31, 2023 | 47.42 Mn |
| Sep 30, 2023 | 38.40 Mn |
| Jun 30, 2023 | 35.36 Mn |
| Mar 31, 2023 | 32.27 Mn |
| Dec 31, 2022 | 32.64 Mn |
| Sep 30, 2022 | 30.02 Mn |
| Jun 30, 2022 | 21.49 Mn |
| Mar 31, 2022 | 21.47 Mn |
| Dec 31, 2021 | 19.82 Mn |
| Sep 30, 2021 | 19.81 Mn |
| Jun 30, 2021 | 16.91 Mn |